▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #358 by analyst upside · 2026-09-27
SION
Sionna Therapeutics, Inc.
Healthcare · Market Cap $236M · P/E 0x
ANALYST PRICE TARGET
+301.5%
implied upside to consensus target
Current Price $5.23
Consensus Target $21.0
Bull Target $63.0
Bear Target $5.0
Analysts Covering 7
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
1
Hold
6
Sell
0
52-Week Low $4.01
52-Week High $54.97
YTD Return -86.7%
FUNDAMENTALS
Market Cap $236M
P/E Ratio (TTM) N/A
Forward P/E N/A
EPS (TTM) $-2.15
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) N/A
Profit Margin N/A
52-WEEK RANGE
52-Week Low $4.01
52-Week High $54.97
Current Price $5.23
Bear Target $5.0
Bull Target $63.0
● Now $5.23 ● Target $21.0
TRADING DATA
Avg Volume 2.1M
YTD Return -86.7%
Analyst Count 7
Consensus Hold
Upside to Target +301.5%
Last Updated 2026-09-27

ANALYST SUMMARY

Sionna Therapeutics, Inc. (SION) is currently trading at $5.23 with a Wall Street consensus price target of $21.0, implying potential upside of 301.5% over the next 12 months. 7 analysts currently cover SION, with a consensus rating of Hold - 14% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $63.0, while the most cautious has a target of $5.0.

SION operates in the Healthcare sector with a market capitalisation of $236M. The stock is down 86.7% year-to-date and is currently trading near the lower end of its 52-week range of $4.01 – $54.97.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for SION, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Wedbush - Reiterated
Neutral → Neutral 2026-09-15 Building track record
Guggenheim ↓ Downgrade
Buy → Neutral 2026-08-11 62% win rate (8 calls)
Wedbush ↓ Downgrade
Outperform → Neutral 2026-08-11 Building track record
BTIG ↓ Downgrade
Buy → Neutral 2026-08-10 38% win rate (8 calls)
Guggenheim - Reiterated
Buy → Buy 2026-08-07 62% win rate (8 calls)
Citizens reit
Market Outperform → Market Outperform 2026-05-26 Building track record
Freedom Broker ↓ Downgrade
Buy → Hold 2026-05-20 Building track record
Stifel - Reiterated
Buy → Buy 2026-05-18 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
18
out of 100
Coverage depth
16/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →